DOI:
10.1055/s-00000099
Zeitschrift für Orthopädie und Unfallchirurgie
LinksClose Window
References
Ehlken B, Nathell L, Gohlke A. et al.
Evaluation of the reported rates of severe hypersensitivity reactions associated with ferric carboxymaltose and iron (III) isomaltoside 1000 in Europe based on data from EudraVigilance and VigiBase™ between 2014 and 2017.
Drug Saf 2019;
42: 463-471
doi:10.1007/s40264-018-0769-5
We do not assume any responsibility for the contents of the web pages of other providers.